Michael Esposito
Education
The Tuck School of Business at Dartmouth
MBA, Business 1979-01-01 - 1981-01-01
Massachusetts College of Pharmacy and Health Sciences
BS Pharmacy, Pharmacy 1974-01-01 - 1978-01-01Work Experience
Norbridge, Inc.
Current
Norbridge, Inc.
Charles River Associates
Current
Charles River Associates
Saladax Biomedical Inc.
2016-07-01 - 2023-11-01
Saladax Biomedical Inc.
Clear Intradermal Technologies, Inc. (YClearIT)
2022-10-01 - 2023-07-01
Clear Intradermal Technologies, Inc. (YClearIT)
Alacrita Consulting
2018-02-01 - 2020-12-01
Alacrita Consulting
Angioblast Systems, Inc. (now Mesoblast)
2002-01-01 - 2010-12-01
Angioblast Systems, Inc. (now Mesoblast)
Aspect Medical Systems
2006-01-01 - 2009-01-01
Aspect Medical Systems
Arthur D. Little
1983-01-01 - 1998-01-01
Arthur D. Little
Pfizer
1981-01-01 - 1983-01-01
Pfizer
Skills
Summary
I have worked as a management consultant with major health care product companies in the US, Europe and Japan for the past 40+ years (e.g., Pharma/Biopharma; Devices and Diagnostics). Engagements have included: Corporate Strategy, Business Development, Marketing (Franchise or Brand) Strategy, Sales Force Effectiveness, Operations Improvement. 1978 B.S. in Pharmacy from Massachusetts College of Pharmacy 1981 M.B.A. from Amos Tuck School at Dartmouth College 1981-1983 Pfizer Pharmaceuticals- Product Management 1983 -1998 Arthur D. Little Vice President and Global Health Care Practice Leader 1998-Present Norbridge, Inc. President and Partner 2018-2020 Alacrita Consulting, Partner 2022-Present Charles River Associates, Senior Consultant Advisor Formerly on the Board of Directors of Saladax Biomedical, Inc. (Private); ClearIT (Private and YClearIT); Aspect Medical Systems (Public) and Angioblast (now Mesoblast). Member of the Board of Advisors of The New Bedford Symphony Orchestra and Member of the Corporations of MCPHS University and The Rotch Jones Duff House & Garden Museum.
